Phreesia, Inc. Common Stock (PHR)

Phreesia, Inc. (NYSEPHR) (“Phreesia” or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2024.

Phreesia, a leader in patient intake, outreach and activation, has been selected by The Software Report as one of the “Top 100 Software Companies of 2024.” The annual program evaluates companies based on a range of criteria, including product functionality, customer satisfaction, corporate reputation, innovative capabilities, organizational depth, ESG involvement and long-term viability. This is the third consecutive year Phreesia has been named to the list.

Phreesia, Inc. (NYSEPHR) (“Phreesia”) today announced that it will release its fiscal third quarter 2025 financial results after the close of market trading on Monday, Dec. 9, 2024. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal third quarter results starting at 5PM Eastern Time on the same day.

Phreesia, a leader in patient intake, outreach and activation, and a member of Oracle PartnerNetwork (OPN), today announced that it has achieved Oracle Validated Integration with Oracle Health Electronic Health Record (EHR) Expertise for its integration of the Phreesia platform. Phreesia gives clients a suite of tools to manage patient intake across care settings and service lines. Its logic-driven tools enable healthcare organizations to operate more efficiently and provide a high-quality patient experience at scale.

As part of the company’s ongoing commitment to consumer data privacy, Phreesia is pleased to announce it has joined the Network Advertising Initiative (NAI), a non–profit organization and the leading self-regulatory association dedicated to responsible data collection and use for digital advertising. As a member, Phreesia will work with the NAI to promote consumer-centric privacy practices in healthcare and take a leadership role in shaping the national conversation around data privacy.

Phreesia, a leader in patient intake, outreach and activation, has collaborated with the Ad Council, a nonprofit organization at the forefront of driving change through social impact marketing, to bring three public health campaigns about mental health directly to patients and caregivers. Collectively across the campaigns, Phreesia has already delivered more than 430,000 messages, helping to spread awareness about the importance of youth and adult mental wellbeing and encouraging more open conversations about mental health.

Phreesia, a leader in patient intake, outreach and activation, is pleased to announce that its contract with the CMS Innovation Center (CMMI) for use of the Patient Activation Measure® (PAM) has been renewed through 2029. The PAM performance measure, which assesses gains in patients’ knowledge, skills and confidence in managing their own healthcare, is one of the first patient-reported outcome performance measures (PRO-PMs) used in a CMS alternative payment model. Under the new contract, Phreesia will provide access to PAM, training, analysis and other support to the Kidney Care Choices Model (KCC). CMMI also has the option to expand the PAM into additional models, including those focused on other disease states, care settings or episodes of care.

New Phreesia research examining more than 20.2 million digital vaccine messages indicates that providing adults and caregivers with vaccine information just before their appointments, or at the point of care, is an effective strategy for supporting vaccine confidence and adoption, including among historically marginalized populations.

Phreesia, a leader in patient intake, outreach and activation, together with the National Association For Continence (NAFC), Health.Equity.Outcomes. and Christina Escobar, MD, at New York University, are proud to announce that the U.S. Centers for Disease Control and Prevention (CDC) has awarded a grant for a joint project focused on combating the public health challenge of urinary incontinence (UI) in women.

Phreesia, Inc. (NYSEPHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2024.

Phreesia, a leader in patient intake, outreach and activation, and the American Academy of Pediatrics (AAP), an organization of 67,000 pediatricians, have joined forces to increase measles, mumps and rubella (MMR) immunization by reaching parents and caregivers of eligible or soon-to-be eligible children at the point of care. The collaboration comes as immunization rates have dipped in some communities, pointing to a need to improve access to the vaccines that can help keep children healthy.

Phreesia, a leader in patient intake, outreach and activation, is pleased to announce it has named Bob Glazer as a Strategic Advisor, leveraging his deep expertise and decades of experience in healthcare leadership to help ensure its offerings continue to meet the evolving needs of its clients.

NEW YORK, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Helen of Troy Limited (NASDAQHELE), Owens & Minor, Inc. NYSE: OMINYSEOMI)(NYSE: CRMNYSECRM, and Phreesia, Inc. (NYSE: PHRNYSE). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.

Phreesia, Inc. (NYSEPHR) (“Phreesia”) today announced that it will release its fiscal second quarter 2025 financial results after the close of market trading on Wednesday, Sept. 4, 2024. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal second quarter results starting at 5PM Eastern Time on the same day.

Phreesia, a leader in patient intake, outreach and activation and a member of Oracle PartnerNetwork (OPN), today announced that Phreesia is available on Oracle Healthcare Marketplace and can be integrated with the Oracle Health Electronic Health Record (EHR). Oracle Healthcare Marketplace is a centralized repository of healthcare applications offered by Oracle and Oracle partners. This new collaboration strengthens Phreesia’s existing integration with Oracle and provides expanded benefits for customers.

NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Phreesia, Inc. (“Phreesia” or the “Company”) (NYSEPHR) on behalf of Phreesia stockholders. Our investigation concerns whether Phreesia has violated the federal securities laws and/or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP is investigating potential claims against Phreesia, Inc. (“Phreesia” or the “Company”) (NYSEPHR). The investigation concerns whether Phreesia and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. (“Phreesia” or “the Company”) (NYSEPHR). Investors who purchased Phreesia securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/PHR.

New research published in The American Journal of Accountable Care by Phreesia, in partnership with The National Kidney Foundation (NKF), found that even eight years after patients are diagnosed with diabetes and/or hypertension, many do not know that these conditions put them at high risk for chronic kidney disease (CKD). The study finds that discussions between a patient and their providers and patient activation play a significant role in detecting and preventing CKD, one of the leading causes of death in the United States.

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. (“Phreesia” or “the Company”) (NYSEPHR). Investors who purchased Phreesia securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/PHR.

Phreesia, Inc. (NYSEPHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2024.

Phreesia, a leader in patient intake, outreach, and activation, has joined the MEDITECH Alliance Program, an ecosystem of partner organizations with proven, successful and interoperable solutions. Through the partnership, MEDITECH customers can leverage Phreesia to deliver a patient-driven registration experience, whether in a hospital-based or ambulatory care setting.

Phreesia is pleased to announce that the healthcare marketing industry trade publication PM360 has named Amy Patel, MPH, Director of Analytics, as one of its 2024 PM360 ELITE 100.

Phreesia, a leader in patient intake, outreach and activation, has been selected by Modern Healthcare as one of the 2024 Best Places to Work in Healthcare. This is the eighth time Phreesia has been named to the list.

Phreesia is pleased to announce that the healthcare marketing industry trade publication MM+M has named Alicia Cowley, MD, MBA, Director of Clinical Content, and Natasha Vega, MS, Senior Client Experience Manager, to its Women to Watch class of 2024.